ASSOCIATION FOR ACCESSIBLE MEDICINE

Lobbying Spend

—

Filings

Firms Hired

Active Period

2020–2022

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2022	—	5	1
2021	—	4	1
2020	—	4	1

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
MAYER BROWN LLP	—	13

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	7
SENATE	6
U.S. Trade Representative (USTR)	3
White House Office	1

Most frequently reported lobbying issues

Issue Code	Description	Reports
Taxation/Internal Revenue Code	Taxation/Internal Revenue Code	7
Trade (domestic/foreign)	Trade (domestic/foreign)	5
Health Issues	Health Issues	3

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

S. 3708117th Congress

Trading System Preservation Act

2022 · second_quarter · Firm: MAYER BROWN LLP

Cited source text and reported amounts

Legislative proposals related to re-shoring of pharmaceutical industry; S. 3708 (Trading System Preservation Act).

Client expense: — · Firm income: $20,000

Matched citations: S. 3708

ASSOCIATION FOR ACCESSIBLE MEDICINE — Lobbying Disclosure | Poliscope